TickerFacts.

CDT Equity Inc. (CDT): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$7.17M
As of 2025-12-31
$103.09M
As of 2026-06-30
$20.6K2021-12-31: $20.6K2022-12-31: -$10.09M2023-03-31: -$12.02M2023-06-30: -$14.51M2023-12-31: -$457.0K2024-12-31: -$6.79M2025-12-31: -$7.17M-$7.17M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$7.17Mn/m2026-04-15, Balance as of period end
2024-12-31-$6.79Mn/m2026-04-15, Balance as of period end
2023-12-31-$457.0Kn/a2025-03-28, Balance as of period end
2023-06-30-$14.51Mn/a2024-04-16, Balance as of period end
2023-03-31-$12.02Mn/a2024-04-16, Balance as of period end
2022-12-31-$10.09Mn/m2024-04-16, Balance as of period end
2021-12-31$20.6Kn/a2023-03-28, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
CDT Equity Inc. (CDT)2025-12-31-$7.17Mn/m
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$1.83Mn/m
AEON Biopharma, Inc. (AEON)2025-12-31-$55.03Mn/m
Ernexa Therapeutics Inc. (ERNA)2025-12-31$2.40M+41.2%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$3.46M-14.2%
Quantum Cyber N.V. (QUCY)2025-12-31$641.6K-89.3%
Polaryx Therapeutics, Inc. (PLYX)2025-12-31$4.57M-3.1%
Greenwich LifeSciences, Inc. (GLSI)2025-12-31$353.2K-61.1%
Petros Pharmaceuticals, Inc. (PTPI)2025-12-31$2.87Mn/m

Compare CDT, JUNS, AEON, ERNA side by side · Screen every company in Pharmaceutical Preparations ↗